Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation - No Study Results Posted

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation (MERONEM)

This study has been completed.

Study NCT00462878 Information provided by PETHEMA Foundation

First Received: April 18, 2007 Last Updated: May 11, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Estimated Primary Completion Date:	No date given